Sonoma Pharmaceuticals (SNOA) Assets Average (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Assets Average of $13.8 million for Q1 2026, up 0.81% year-over-year from $13.7 million in Q1 2025, and little changed quarter-over-quarter from $13.7 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Assets Average (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Assets Average history runs 16 years deep, the most recent figure standing at $13.8 million for Q1 2026.
- In Q1 2026, Assets Average rose 0.81% year-over-year to $13.8 million; the TTM figure through Mar 2026 stood at $13.8 million (up 0.81% YoY), while the FY2026 annual figure was $13.8 million, down 2.74% from the prior year.
- Assets Average for Q1 2026 stood at $13.8 million, roughly flat from $13.7 million in the prior quarter.
- The five-year high for Assets Average was $19.1 million in Q1 2022, with the low at $13.7 million in Q4 2024.
- The 5-year median for Assets Average is $14.2 million (2025), against an average of $14.9 million.
- Peak annual rise in Assets Average reached 23.69% in 2022, while the deepest fall reached 26.25% in 2022.
- Sonoma Pharmaceuticals' Assets Average stood at $14.4 million in 2022, then fell by 2.2% to $14.1 million in 2023, then retreated by 3.19% to $13.7 million in 2024, then rose by 0.46% to $13.7 million in 2025, then rose by 0.38% to $13.8 million in 2026.
- Business Quant data shows SNOA's Assets Average at $13.8 million in Q1 2026, $13.7 million in Q4 2025, and $14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 16.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.03 Mn |
| Mar 31, 2026 | 13.79 Mn |
| Dec 31, 2025 | 13.74 Mn |
| Sep 30, 2025 | 14.23 Mn |
| Jun 30, 2025 | 14.14 Mn |
| Mar 31, 2025 | 13.68 Mn |
| Dec 31, 2024 | 13.68 Mn |
| Sep 30, 2024 | 13.68 Mn |
| Jun 30, 2024 | 14.21 Mn |
| Mar 31, 2024 | 14.68 Mn |
| Dec 31, 2023 | 14.13 Mn |
| Sep 30, 2023 | 14.76 Mn |
| Jun 30, 2023 | 16.06 Mn |
| Mar 31, 2023 | 15.08 Mn |
| Dec 31, 2022 | 14.45 Mn |
| Sep 30, 2022 | 16.06 Mn |
| Jun 30, 2022 | 18.00 Mn |
| Mar 31, 2022 | 19.10 Mn |
| Dec 31, 2021 | 19.59 Mn |
| Sep 30, 2021 | 16.97 Mn |